Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
Avicanna Announces Closing of Non-Brokered Private Placement
Avicanna Reports Q1 2026 Financial Statements
Avicanna Inc. (AVCN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Avicanna Announces Results of Annual General and Special Meeting
Avicanna Announces Change in Board of Directors
Avicanna Announces Change in Board of Directors
Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
Annual General and Special Meeting of Shareholders to be held May 7, 2026
ThreeD Capital Inc. Issues Early Warning Report in Connection with Disposition of Securities of Avicanna Inc.
Avicanna Inc. (AVCN:CA) Q4 2025 Earnings Call Transcript
Avicanna Announces Changes to its Board of Directors
Avicanna Reports Full Year 2025 Audited Financial Statements
Avicanna Subsidiary SMGH Completes First Commercial Export to Australia
Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial
Avicanna Announces Closing of Non-Brokered Private Placement
Avicanna Announces Medical Cannabis Real World Evidence Results and Publication
Avicanna Announces Changes to its Board of Directors
Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update
ThreeD Capital Inc. Issues Early Warning Report in Connection with Disposition of Securities of Avicanna Inc.
Avicanna Inc. (AVCN:CA) Discusses Strategic Pivot, Business Pillars, and Pharmaceutical Pipeline Progress Transcript
Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform
Avicanna Reports Q3 2025
Avicanna Announces Change in CFO
Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland
Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States
Avicanna Reports Q2 2025
Avicanna Announces US Patent and Trademark Office Issuance of New Patent
Avicanna Announces Closing of Non-Brokered Private Placement
Avicanna Announces Results of Annual General Meeting
Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
Avicanna Reports Q1 2025 Results and First Profitable Quarter
Avicanna Inc. (AVCNF) Q4 2024 Earnings Call Transcript
Avicanna Announces Revocation of Management Cease Trade Order
Avicanna Reports Full Year 2024 Audited Financial Statement
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
ThreeD Capital Inc. Issues Early Warning Report in Connection with Acquisition of Securities of Avicanna Inc.
Avicanna To Hold Full Year 2024 Earnings Conference Call
Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma
Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company
Avicanna Reports Q3 2024
Avicanna Announces Closing of Non-Brokered Private Placement
ThreeD Capital Inc. Issues Early Warning Report in Connection with Acquisition of Securities of Avicanna Inc.
Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca
Avicanna Announces Repayment of Debentures
Avicanna Announces Closing of Non-Brokered Private Placement
Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology
Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark